Last quarter (Q4 2023), Catalyst Pharma's total revenue was $110.57M, an increase of 81.98% from the same quarter last year. In Q4, Catalyst Pharma's net income was $34.84M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 398.10M	$ 398.20M	$ 214.20M	$ 140.83M	$ 119.07M	$ 102.31M
Cost of Revenue	$ 51.97M	$ 51.97M	$ 34.39M	$ -21.88M	$ 17.04M	$ 14.76M
Gross Profit	$ 346.24M	$ 346.24M	$ 179.81M	$ 118.95M	$ 102.03M	$ 87.55M
Operating Expense	$ 239.92M	$ 226.86M	$ 77.97M	$ 66.56M	$ 60.73M	$ 55.72M
Operating Income	$ 103.79M	$ 86.81M	$ 101.84M	$ 52.38M	$ 41.30M	$ 31.82M
Net Non Operating Interest Income Expense	-	-	-	-	-	$ 1.59M
Other Income Expense	$ -7.70M	$ -7.70M	$ -2.88M	$ -282.00K	$ 587.00K	$ 1.59M
Pretax Income	$ 94.51M	$ 94.51M	$ 104.72M	$ 52.67M	$ 41.89M	$ 33.41M
Tax Provision	$ 23.10M	$ 23.10M	$ 21.64M	$ 13.19M	$ -33.09M	$ 1.53M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 79.90M	$ 71.41M	$ 83.08M	$ 39.48M	$ 74.98M	$ 31.88M
Basic EPS	$ 0.68	$ 0.67	$ 0.80	$ 0.38	$ 0.72	$ 0.31
Diluted EPS	$ 0.59	$ 0.63	$ 0.75	$ 0.37	$ 0.71	$ 0.30
Basic Average Shares	$ 425.12M	$ 106.28M	$ 103.37M	$ 103.38M	$ 103.51M	$ 102.94M
Diluted Average Shares	$ 455.01M	$ 113.75M	$ 111.38M	$ 107.80M	$ 106.24M	$ 106.02M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ 0.78	$ 0.35
Reported Normalized Diluted E P S	-	-	-	-	$ 0.76	$ 0.34
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 291.89M	$ 278.83M	$ 112.36M	$ 44.68M	$ 77.77M	$ 70.48M
Net Income From Continuing And Discontinued Operation	$ 71.41M	$ 71.41M	$ 83.08M	$ 39.48M	$ 74.98M	$ 31.88M
Normalized Income	$ -6.95M	-	$ 82.73M	-	$ 74.98M	$ 31.88M
Interest Expense	-	-	-	-	-	-
EBIT	$ 94.51M	$ 94.51M	$ 104.72M	$ 52.67M	$ 41.30M	$ 31.82M
EBITDA	$ 127.39M	$ 127.39M	$ 105.96M	$ 52.86M	$ 41.40M	$ 32.12M

Currency in USD

Catalyst Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing